Nichols Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Nichols Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,130	Closed	-$466K	–	68
2016 Q3	$466K	Hold	10,130	–	–	0.87%	41
2016 Q2	$509K	Hold	10,130	–	–	1.03%	31
2016 Q1	$542K	Hold	10,130	–	–	0.12%	73
2015 Q4	$665K	Hold	10,130	–	–	0.14%	68
2015 Q3	$572K	Hold	10,130	–	–	0.13%	77
2015 Q2	$599K	Hold	10,130	–	–	0.11%	81
2015 Q1	$631K	Hold	10,130	–	–	0.11%	82
2014 Q4	$583K	Hold	10,130	–	–	0.11%	82
2014 Q3	$544K	Hold	10,130	–	–	0.11%	84
2014 Q2	$531K	Hold	10,130	–	–	0.11%	86
2014 Q1	$535K	Hold	10,130	–	–	0.12%	87
2013 Q4	$406K	Hold	10,130	–	–	0.08%	98
2013 Q3	$383K	Hold	10,130	–	–	0.11%	97
2013 Q2	$397K	Buy	+10,130	New	+$394K	0.12%	90

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Nichols Asset Management's TEVA Position: Q4 2016 in Review

Nichols Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 10,130 shares — an estimated $466K sold.

Nichols Asset Management first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $665K in Q4 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Nichols Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Nichols Asset Management sold 10,130 Teva Pharmaceuticals shares in Q4 2016, an estimated $466K.
Nichols Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Nichols Asset Management's Teva Pharmaceuticals position peaked at $665K in Q4 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Nichols Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.